Caffeinated clues from epidemiology of Parkinson’s disease
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Although there is a growing interest in the genetic determinants of Parkinson’s disease (PD), the low concordance for clinical disease among monozygotic twins clearly indicates the etiologic importance of nongenetic factors.1 On top of the list of potential candidates is cigarette smoking. For many years, researchers have been intrigued by the strong inverse association between cigarette smoking and risk of PD, but despite extensive investigation it remains unclear whether nicotine or some other component of cigarette smoke reduces the risk of PD or whether people predisposed to PD have an early aversion to smoking.2 More recently, coffee and caffeine consumption have emerged as powerful predictors of risk of PD. Here we will review the epidemiologic evidence supporting this association and discuss the contribution of epidemiologic studies in clarifying the potential biologic mechanisms. Whereas the inverse association between cigarette smoking and risk of PD has been known for decades, relatively few early studies examined the potential role of coffee or caffeine consumption. Questions on coffee and tea consumption and risk of PD were included in some of the case-control studies on smoking3,4⇓ or environmental factors5 and risk of PD, but published results were not adjusted for smoking and thus were difficult to interpret. The first smoking-adjusted analysis of coffee consumption and PD was reported by Jimenez-Jimenez et al.,6 who studied 128 patients with PD (60 women) attending a movement disorder clinic in Madrid and 256 control subjects attending the emergency room of the same hospital for non-neurologic disorders. The data supported a 30% lower risk of PD among coffee drinkers (coffee drinking was reported as yes/no only) as compared with nondrinkers in men and women, but the results were not significant and received little attention. More detailed analyses of coffee consumption and risk of PD …
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624
A meta‐analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease
Hernán, M. A., Takkouche, B., Caamaño‐Isorna, F., & Gestal‐Otero, J. J. (2002) · Annals of Neurology · doi:10.1002/ana.10277 · Cited by 818
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Prospective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Self-citationSmoking, alcohol, and coffee consumption preceding Parkinson’s disease: A case-control study
Benedetti, M. D., Bower, J. H., Maraganore, D. M., McDonnell, S. K., Peterson, B. J., Ahlskog, J. E., Schaid, D. J., & Rocca, W. A. (2000) · Neurology · doi:10.1212/wnl.55.9.1350 · Cited by 234
Impairment of Caffeine Clearance by Chronic Use of Low-Dose Oestrogen-Containing Oral Contraceptives
Abernethy, D. R., & Todd, E. L. (1985) · European Journal of Clinical Pharmacology · doi:10.1007/bf00544361 · Cited by 195
Cited by
Coffee and Health: A Review of Recent Human Research
Higdon, J. V., & Frei, B. (2006) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408390500400009 · Cited by 1,090
Novel pharmacological targets for the treatment of Parkinson's disease
Schapira, A. H. V., Bezard, E., Brotchie, J., Calon, F., Collingridge, G. L., Ferger, B., Hengerer, B., Hirsch, E., Jenner, P., Novère, N. L., et al. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2087 · Cited by 298
Caffeine for treatment of Parkinson disease: A randomized controlled trial
Postuma, R. B., Lang, A. E., Munhoz, R. P., Charland, K., Pelletier, A., Moscovich, M., Filla, L., Zanatta, D., Rios Romenets, S., Altman, R., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e318263570d · Cited by 298
Psychostimulants and Cognition: A Continuum of Behavioral and Cognitive Activation
Wood, S., Sage, J. R., Shuman, T., & Anagnostaras, S. G. (2014) · Pharmacological Reviews · doi:10.1124/pr.112.007054 · Cited by 259
Caffeine Intake is Associated with a Lower Risk of Cognitive Decline: A Cohort Study from Portugal
Santos, C., Lunet, N., Azevedo, A., de Mendonça, A., Ritchie, K., & Barros, H. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091303 · Cited by 100
Metadata
- Authors
- Ascherio, A., & Chen, H.
- Venue
- Neurology
- Published
- 2003-12-09
- Volume
- 61
- Issue
- 11_suppl_6
- Pages
- S51-4
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2082732384
- Cited by
- 46
- References
- 6
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Caffeinated clues from epidemiology of Parkinson’s disease. https://app.cochat.ai/papers/10.1212/01.wnl.0000095213.86899.21
- The paper
- Ascherio, A., & Chen, H. (2003). Caffeinated clues from epidemiology of Parkinson’s disease. Neurology. https://doi.org/10.1212/01.wnl.0000095213.86899.21
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.